Clinical trial
A Randomized Prospective Multicenter Trial to Examine Vascular Healing at 1 and 6 Month(s) After Deployment of TItanium-nitride-oxide-coated OPTIMAX™ Bio-active-stent (BAS) Stent and SYNERGY™ Everolimus-Eluting Stent (EES) in Patients With Acute Coronary Syndromes by Means of Optical Coherence Tomography
NCT02464397 is registered in ClinicalTrials.gov with The Hospital District of Satakunta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Prospective Multicenter Trial to Examine Vascular Healing at 1 and 6 Month(s) After Deployment of TItanium-nitride-oxide-coated OPTIMAX™ Bio-active-stent (BAS) Stent and SYNERGY™ Everolimus-Eluting Stent (EES) in Patients With Acute Coronary Syndromes by Means of Optical Coherence Tomography
- Lead sponsor
- The Hospital District of Satakunta
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 28, 2015
- Completion date
- August 31, 2017
- Enrollment
- 110 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.